Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation
Tim Hendrikx, Bernd Schnabl
Journal of Internal Medicine (2019) Vol. 286, Iss. 1, pp. 32-40
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Regulation of Intestinal Barrier Function by Microbial Metabolites
Sweta Ghosh, Caleb S. Whitley, Bodduluri Haribabu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 11, Iss. 5, pp. 1463-1482
Open Access | Times Cited: 442
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Ashley Beam, Elizabeth Clinger, Lei Hao
Nutrients (2021) Vol. 13, Iss. 8, pp. 2795-2795
Open Access | Times Cited: 340
Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota–Immune System Interplay. Implications for Health and Disease
Cielo García‐Montero, Oscar Fraile‐Martínez, Ana M. Gómez-Lahoz, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 699-699
Open Access | Times Cited: 289
Human gut microbiota in health and disease: Unveiling the relationship
Muhammad Afzaal, Farhan Saeed, Yasir Abbas Shah, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 286
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 278
Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
Sonja Lang, Bernd Schnabl
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 233-244
Open Access | Times Cited: 168
Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
Shumin Zhang, Jingwen Zhao, Fei Xie, et al.
Obesity Reviews (2021) Vol. 22, Iss. 11
Closed Access | Times Cited: 136
New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases
Xiaojing Li, Binbin Zhang, Yiyang Hu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 132
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 128
Dual Role of Indoles Derived From Intestinal Microbiota on Human Health
Xuewei Ye, Haiyi Li, Komal Anjum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 113
Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome
Elaine Holmes, Julien Wist, Reika Masuda, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 6, pp. 3315-3329
Open Access | Times Cited: 106
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Jiaqiang Wu, Kangping Yang, Hancheng Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 58
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 3, pp. 201-222
Open Access | Times Cited: 51
Necrotizing enterocolitis, gut microbes, and sepsis
Johannes W. Duess, Maame Efua Sampah, Carla M. Lopez, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer
Yingjian Hou, Jing Li, Shuhuan Ying
Metabolites (2023) Vol. 13, Iss. 11, pp. 1166-1166
Open Access | Times Cited: 41
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Yu-Chen Wang, Yen Chin Koay, Calvin Pan, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 371-389
Open Access | Times Cited: 38
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation
Nidesha Randeni, Matteo Bordiga, Baojun Xu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9366-9366
Open Access | Times Cited: 15
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease
Giovanni Addolorato, Francesca Romana Ponziani, Tommaso Dionisi, et al.
Liver International (2020) Vol. 40, Iss. 4, pp. 878-888
Closed Access | Times Cited: 90
Kynurenic acid and cancer: facts and controversies
Katarzyna Walczak, Artur Wnorowski, Waldemar A. Turski, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 8, pp. 1531-1550
Open Access | Times Cited: 86
Diverse roles of microbial indole compounds in eukaryotic systems
Prasun Kumar, Jin‐Hyung Lee, Jintae Lee
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2021) Vol. 96, Iss. 6, pp. 2522-2545
Open Access | Times Cited: 73
Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer
Madhur Wyatt, K. Leigh Greathouse
Nutrients (2021) Vol. 13, Iss. 4, pp. 1189-1189
Open Access | Times Cited: 71
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota
Han Yin, Zhuangzhuang Miao, Lu Wang, et al.
Aging (2022) Vol. 14, Iss. 4, pp. 1941-1958
Open Access | Times Cited: 65
Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases
Charlotte Teunis, Max Nieuwdorp, Nordin M.J. Hanssen
Metabolites (2022) Vol. 12, Iss. 6, pp. 514-514
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top